The size of the Europe Chromatography Resin Market is forecasted to value USD 0.91 billion by 2026 from USD 0.64 billion in 2021, registering a CAGR of 7.2% from 2021 to 2026.
Y-O-Y growth in the amounts being spent on the R&D by the pharmaceutical and biotechnological companies is one of the prominent factors supporting the European Chromatography Resin Market. Growing demand for chromatography resin among the food & beverages, water and environmental, and pharmaceutical and biotechnology industries significantly boosts the European market. The usage of chromatography resins has increased due to the increased manufacturing of drugs such as monoclonal antibodies and other recombinant proteins.
At present, The European countries have kept their prime focus on chemical compound analysis to help control the current COVID-19 eruption. The rising demand for antibody therapeutics, growth in the development of new resins, and extensive use of chromatography among the end-users such as water and environmental, and F&B are further expected to drive the European chromatography resin market.
The European Medical Agency is keen and taking various initiatives to maintain the drug quality and food security; this factor is expected to act favorably to the European market during the forecast period. Pharmaceuticals and food analytics are the major chromatography resin applications in Europe.
The growing significance of green chromatography is expected to offer lucrative opportunities for the European market during the forecast period. The rising demand for biosimilars is also a supporting factor.
However, the shortage of expert professionals and rising pricing pressure are some restraining factors to the European chromatography resin market. The highly organized biologics sector is a challenge for chromatography resin suppliers in Europe.
This research report on the Europe Chromatography Resin Market has been segmented and sub-segmented into the following categories:
By Type:
By Technique:
By Application:
By Country:
Geographically, the Europe chromatography resin market is projected to grow at a healthy rate during the forecast period. Majorly countries such as Germany, UK, France, and Italy provide a significant boost to the European chromatography resin market. The robust existence of pharmaceutical manufacturers and research organizations in countries such as Spain and Switzerland are expected to promote the European market during the forecast period.
The German chromatography resin market is forecasted to play a leading role in the European market during the forecast period. The German market is majorly driven by the growing concerns for high-quality food standards and increasing government funding for drug discovery research.
The UK chromatography resin market is one of the fastest-growing regional markets globally and is expected to register a healthy growth rate during the forecast period. BioToolomics Ltd, a UK-based biotech company, launched a novel and highly efficient disposable chromatography column technology, and this provides 40% to 100% in separation efficiency.
The France chromatography resin market is predicted to showcase a notable growth rate during the forecast period due to the increasing demand for drug discovery to fight against diseases such as Zika and Ebola viruses, which helps accumulate the chromatography resin market growth in Europe.
KEY MARKET PLAYERS:
Bio-Rad Laboratories Inc., GE Healthcare, Tosoh Corporation, Merck KGaA, Pall Corporation, Avantor Performance Materials Inc., Mitsubishi Chemical Corporation, Purolite Corporation, Repligen Corporation, and Thermo Fisher Scientific Inc. are a few of the promising companies in the European chromatography resins market.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technique
5.1.1 Introduction
5.1.2 Affinity
5.1.2.1 Bio-Specific Ligand-Based Affinity Chromatography
5.1.2.1.1 Protein A Affinity
5.1.2.1.2 Protein G Affinity
5.1.2.1.3 Protein l Affinity
5.1.2.1.4 Lectin L Affinity
5.1.2.1.5 Others
5.1.2.2 Pseudo Bio-Specific Ligand-Based Affinity Chromatography
5.1.2.2.1 Imac
5.1.2.2.2 Dye Ligands-Based
5.1.2.2.3 Others
5.1.3 Hydrophobic Interaction
5.1.4 Ion Exchange
5.1.4.1 Cation Exchange Chromatography
5.1.4.2 Anion Exchange Chromatography
5.1.5 Multi-modal
5.1.6 Size Exclusion
5.1.7 Others
5.1.7.1 Partition Chromatography
5.1.7.2 Adsorption Chromatography
5.1.8 Y-o-Y Growth Analysis, By Technique
5.1.9 Market Attractiveness Analysis, By Technique
5.1.10 Market Share Analysis, By Technique
5.2 Type
5.2.1 Introduction
5.2.2 Natural Polymer
5.2.3 Inorganic Media
5.2.4 Synthetic Polymer
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Food & Beverage
5.3.3 Pharmaceutical & Biotechnology
5.3.3.1 Production
5.3.3.2 Academics & Research
5.3.4 Water & Environmental Analysis
5.3.5 Disease Risk Assessment
5.3.6 Others
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technique
6.1.3.3 By Type
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technique
6.1.4.3 By Type
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technique
6.1.5.3 By Type
6.1.5.4 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
6.7 Rest of Europe
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Avantor Performance Materials, Inc.
8.4 Bio-Rad Laboratories, Inc.
8.5 Mitsubishi Chemical Corporation
8.6 Purolite Corporation
8.7 Merck KGaA
8.8 Pall Corporation
8.9 Repligen Corporation
8.10 Tosoh Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
